Therefore, EBV+ DLBCL cells could have high PD-L1 and mPD-L1 expressions and thus it is assumed that EBV+ DLBCL patients has a poorer prognosis than EBV− those. Here, CD274 is linked to diffuse large B-cell lymphoma.